CA

CHI Advisors Portfolio holdings

AUM $252M
1-Year Est. Return 57.46%
This Quarter Est. Return
1 Year Est. Return
+57.46%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$329M
AUM Growth
-$47.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
30
New
Increased
Reduced
Closed

Top Buys

1
+$55.7M
2
+$5.67M
3
+$5.56M
4
LABD icon
Direxion Daily S&P Biotech Bear 3X Shares
LABD
+$4.67M
5
RARE icon
Ultragenyx Pharmaceutical
RARE
+$3.92M

Top Sells

1
+$100M
2
+$41.7M
3
+$4.9M
4
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
+$3.13M
5
KZR icon
Kezar Life Sciences
KZR
+$2.16M

Sector Composition

1 Healthcare 98.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KZR icon
26
Kezar Life Sciences
KZR
$45.6M
– –
-68,945
TRDA icon
27
Entrada Therapeutics
TRDA
$242M
– –
-56,374
KDNY
28
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
– –
-135,000
ONCR
29
DELISTED
Oncorus, Inc.
ONCR
– –
-2,367,436
RXDX
30
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
– –
-934,135
1
2